Shopping Cart 0
Cart Subtotal
AED 0

Rutgers The State University of New Jersey - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Rutgers The State University of New Jersey (Rutgers) is a research university that offers undergraduate and postgraduate programs, and research in the areas of health sciences. The university provides continuing education for professional and personal advancement. It offers courses in the areas of accounting and information systems, aerospace engineering, Africana studies, agricultural and resource management agents, agricultural, food, and resource economics, environmental sciences, epidemiology, and others. Rutgers operates through its campuses in New Brunswick, Newark, and Camden. The university provides services, solutions, and clinical care for individuals and the local, national, and global communities. Rutgers is headquartered in New Brunswick, New Jersey, the US.

Rutgers The State University of New Jersey-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Rutgers The State University of New Jersey, Medical Devices Deals, 2012 to YTD 2018 9

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

BioMotiv Forms Joint Venture with Rutgers University 12

Immunicum Enters into Research Agreement with Rutgers Cancer Institute 13

Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 14

Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 15

Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 16

Licensing Agreements 17

Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 17

Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 19

Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 21

WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22

Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23

Rutgers The State University of New Jersey-Key Competitors 24

Rutgers The State University of New Jersey-Key Employees 25

Rutgers The State University of New Jersey-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Joint Venture 27

Recent Developments 28

Government and Public Interest 28

Jun 26, 2018: Pancreatic Cancer Action Network Funds Innovative Scientists through Research Grants Program 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Rutgers The State University of New Jersey, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Key Facts 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Rutgers The State University of New Jersey, Deals By Therapy Area, 2012 to YTD 2018 8

Rutgers The State University of New Jersey, Medical Devices Deals, 2012 to YTD 2018 9

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioMotiv Forms Joint Venture with Rutgers University 12

Immunicum Enters into Research Agreement with Rutgers Cancer Institute 13

Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 14

Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 15

Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 16

Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 17

Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 19

Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 21

WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22

Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23

Rutgers The State University of New Jersey, Key Competitors 24

Rutgers The State University of New Jersey, Key Employees 25

Rutgers The State University of New Jersey, Other Locations 26

Rutgers The State University of New Jersey, Subsidiaries 26

Rutgers The State University of New Jersey, Joint Venture 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Rutgers The State University of New Jersey, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Rutgers The State University of New Jersey (Rutgers) is a research university that offers undergraduate and postgraduate programs, and research in the areas of health sciences. The university provides continuing education for professional and personal advancement. It offers courses in the areas of accounting and information systems, aerospace engineering, Africana studies, agricultural and resource management agents, agricultural, food, and resource economics, environmental sciences, epidemiology, and others. Rutgers operates through its campuses in New Brunswick, Newark, and Camden. The university provides services, solutions, and clinical care for individuals and the local, national, and global communities. Rutgers is headquartered in New Brunswick, New Jersey, the US.

Rutgers The State University of New Jersey-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Rutgers The State University of New Jersey, Medical Devices Deals, 2012 to YTD 2018 9

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

BioMotiv Forms Joint Venture with Rutgers University 12

Immunicum Enters into Research Agreement with Rutgers Cancer Institute 13

Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 14

Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 15

Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 16

Licensing Agreements 17

Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 17

Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 19

Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 21

WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22

Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23

Rutgers The State University of New Jersey-Key Competitors 24

Rutgers The State University of New Jersey-Key Employees 25

Rutgers The State University of New Jersey-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Joint Venture 27

Recent Developments 28

Government and Public Interest 28

Jun 26, 2018: Pancreatic Cancer Action Network Funds Innovative Scientists through Research Grants Program 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Rutgers The State University of New Jersey, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Key Facts 2

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Rutgers The State University of New Jersey, Deals By Therapy Area, 2012 to YTD 2018 8

Rutgers The State University of New Jersey, Medical Devices Deals, 2012 to YTD 2018 9

Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioMotiv Forms Joint Venture with Rutgers University 12

Immunicum Enters into Research Agreement with Rutgers Cancer Institute 13

Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 14

Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 15

Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 16

Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 17

Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 19

Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 21

WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22

Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23

Rutgers The State University of New Jersey, Key Competitors 24

Rutgers The State University of New Jersey, Key Employees 25

Rutgers The State University of New Jersey, Other Locations 26

Rutgers The State University of New Jersey, Subsidiaries 26

Rutgers The State University of New Jersey, Joint Venture 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Rutgers The State University of New Jersey, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.